24/7 BIOPHARMA | NEWSLETTER MAY 2026

cover DIGITALE nl MAY 2026

Faggi https://youtu.be/kR2FdlNVwas banner FAGGI

DCAT https://youtu.be/JuFNMaNr2Hw Lonza and Oxford Nanopore Technologies Launch Direct RNA Sequencing Solution for GMP mRNA Quality Control Oxford Nanopore Technologies, a company delivering a new generation of nanoporebased molecular sensing technology, and Lonza today announced the launch of a new technology approach designed to modernize and accelerate GMP quality control testing for mRNA therapeutics. The solution combines direct RNA sequencing using nanopore technology with bespoke machine learningbased data analysis and customized software intended to help close the gap between the rapid pace of mRNA innovation and the slower evolution of analytical methods. mRNA therapeutics have... READ MORE

Kindeva https://youtu.be/TxtWHrTqX9Y

Quotient Sciences Advances AI-Designed Drug Product into Clinical Development Quotient Sciences announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) – a landmark achievement highlighting the growing potential of AI to guide formulation design and accelerate drug development. The pioneering Phase I clinical study was initiated at Quotient Sciences’ UK facility following approval from the Medicines and Healthcare products Regulatory Agency (MHRA). The study will assess the safety and pharmacokinetics of an oral solid dose formulation in healthy volunteers. A key objective of the study is to validate the use of AI in drug product development, demonstrating the potential of AI to accelerate formulation design... READ MORE DCAT https://youtu.be/Ut1LAt9MGKg

Interview with Mrs. Sara Bacchiega, Ph.D Business Development Manager & Patent Expert What types of skills do women in the pharmaceutical industry need to develop? Women have historically been attracted to pharmacy and have continued to be drawn to scientific disciplines, as is evident from the rising percentage of women working in the pharmaceutical field. Cultivating strong technical skills is the essential starting point for success in the pharmaceutical field, but that’s not all. What truly makes the difference is the ability to recognize, develop, and unleash our innate soft skills. As women, we are naturally inclined toward flexibility, empathy, active listening, and effective communication— powerful strengths that allow us to lead, collaborate, and inspire. Passion, determination, enthusiasm, and curiosity have always been key drivers of growth but it was when I firmly believed in my abilities that I truly made a difference. The advice I would offer is to pursue something you are deeply passionate about, dedicate yourself fully to achieving your goals. What advice would you give women aspiring to follow your path? Considering that we spend a large part of our lives at work, it’s important to try to do something we truly enjoy—and that’s not always easy. While it’s often clear what we WOMEN IN SCIENCE

don’t like, discovering what we do like can be much more challenging. After completing my PhD in chemistry, I realized that continuing to work in the lab was not for me. But figuring out what I did want to do, and who I wanted to become, was not easy. I stumbled upon patent work by chance, and ever since, I haven’t been able to let it go. Yet it wasn’t simple—I had to study hard and I continue to do so. That’s why the advice I would give is: don’t be afraid to take risks, step out of your comfort zone, and put yourself out there. How does procos spa encourage the progression of more women in specialties/pharma/life sciences? I started working at Procos more than 10 years ago, and since then, I’ve witnessed the number of women grow year after year. What truly stands out to me about Procos is its ability to recognize not only a woman’s professional skills but her full range of competencies—both technical expertise and soft skills. It’s inspiring to see that more and more women are stepping into high-level, strategic roles, shaping the direction of the company and making a real impact. This shows that when talent is recognized and nurtured, women can excel, lead, and make a difference at every level. Alicia Xaka Associate Director, Business Development - US & Canada We’re excited to feature Alicia Xaka, of Procos SpA, a company renowned for its customer-centric approach to custom synthesis and innovative solutions in the API industry... LISTEN TO THE PODCAST

VIDEO INTERVISTA GRIFOLS https://youtu.be/CgcVOBaWfnI

Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufacturers across Asia better local access to downstream process development support. Strategically located to serve customers throughout the region, the site is Ecolab’s first bioprocessing facility in Asia and joins an established applications network in the United States and the United Kingdom. BPAL Korea supports process development from earlystage resin screening through studies designed to replicate commercial... READ MORE Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America SK bioscience announced that it has signed an agreement with Colombia’s state-owned pharmaceutical company VECOL for vaccine technology transfer and local manufacturing cooperation as part of Colombia’s national vaccine localization initiative. The initiative is jointly led by Colombia’s Ministry of Health and Social Protection, the National Health Institute (Instituto Nacional de Salud, INS), and VECOL, with the goal of strengthening national vaccine self-sufficiency and public health preparedness. The project represents a major government-led initiative with a total investment of approximately... READ MORE banner cphi americas

CordenPharma, a leading global Contract Development and Manufacturing Organization (CDMO), today announces that it has entered into an agreement to acquire AmbioPharm, a U.S.- headquartered peptide API CDMO. Adding complementary peptide API capabilities: With its two sites in South Carolina (USA) and Shanghai (China), AmbioPharm adds differentiated peptide manufacturing capabilities to CordenPharma’s existing Peptides Platform and expertise. Once combined, these will include advanced linear and fragment-based peptide approaches supported by flexible... READ MORE CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity Eli Lilly Acquires Engage Bio in $202 Million Deal Engage Biologics, a biotechnology company advancing novel non-viral DNA delivery systems, announced that it had been acquired by Eli Lilly & Company on May 20th, 2026. According to a company press release, Lilly will pay up to $202 million in cash, including upfront and milestone payments, for the acquisition. Additional financial details were not disclosed in the announcement. Engage’s Tethosome platform is a novel non-viral DNA delivery system that combines engineered DNA payloads with lipid nanoparticle delivery and a proprietary mRNA-encoded technology... READ MORE

banner SUNRESIN VIDEO INTERVISTA sunresin https://www.youtube.com/watch?v=R025eYhF3Kk

VIDEO INTERVISTA ENZENE https://youtu.be/hw6TDqz4lHU banner enzene

RkJQdWJsaXNoZXIy MjY2OTA4MA==